APO RESEARCH · REPORT
Live Cell Encapsulation
Live cell encapsulation has long been proposed as a solution in modern medicine to many therapeutic problems. Cell encapsulation technology is used for the immobilization of cells within biocompatible and semipermeable membranes. The encapsulation of cells, instead of therapeutic products, is used to allow the delivery of molecules of interest for a longer time period as cells release these molecules of interest continuously. Furthermore, cells can be engineered for expressing the protein of interest in vivo without modifying the host’s genome. Cell encapsulation presents a significant advantage compared to protein encapsulation, as cell encapsulation allows a sustained and controlled delivery therapeutic molecules at a constant rate, thereby resulting in greater physiological concentrations.
Product & engineering
Understand the product.
Live cell encapsulation has long been proposed as a solution in modern medicine to many therapeutic problems. Cell encapsulation technology is used for the immobilization of cells within biocompatible and semipermeable membranes. The encapsulation of cells, instead of therapeutic products, is used to allow the delivery of molecules of interest for a longer time period as cells release these molecules of interest continuously. Furthermore, cells can be engineered for expressing the protein of interest in vivo without modifying the host’s genome. Cell encapsulation presents a significant advantage compared to protein encapsulation, as cell encapsulation allows a sustained and controlled delivery therapeutic molecules at a constant rate, thereby resulting in greater physiological concentrations.
The Live Cell Encapsulation industry can be broken down into several segments, Alginate, HEMA-MMA, etc.
Across the world, the major players cover BioTime, Reed Pacific, Viacyte, etc.
Selected research
Market Structure
Global Live Cell Encapsulation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Live cell encapsulation has long been proposed as a solution in modern medicine to many therapeutic problems. Cell encapsulation technology is used for the immobilization of cells within biocompatible and semipermeable membranes. The encapsulation of cells, instead of therapeutic products, is used to allow the delivery of molecules of interest for a longer time period as cells release these molecules of interest continuously. Furthermore, cells can be engineered for expressing the protein of interest in vivo without modifying the host’s genome. Cell encapsulation presents a significant advantage compared to protein encapsulation, as cell encapsulation allows a sustained and controlled delivery therapeutic molecules at a constant rate, thereby resulting in greater physiological concentrations.
The Live Cell Encapsulation industry can be broken down into several segments, Alginate, HEMA-MMA, etc.
Across the world, the major players cover BioTime, Reed Pacific, Viacyte, etc.
Read the full market overview
Global Live Cell Encapsulation key players include Viacyte, Inc., Living Cell Technologies Ltd., Sigilon Therapeutics, Inc, Sernova Corporation, PharmaCyte Biotech Inc, Gloriana Therapeutics, Kadimastem, Beta-O2 Technologies, Inc., Altucell, Inc., Diatranz Otsuka Ltd, etc.
Report Includes
This report provides an overview of the global Live Cell Encapsulation market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Live Cell Encapsulation and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Live Cell Encapsulation revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Live Cell Encapsulation market size, projected growth trends, production technologies, key applications, and end-use industries.
Live Cell Encapsulation Segment by Company
Viacyte, Inc.
Living Cell Technologies Ltd.
Sigilon Therapeutics, Inc
Sernova Corporation
PharmaCyte Biotech Inc
Gloriana Therapeutics
Kadimastem
Beta-O2 Technologies, Inc.
Altucell, Inc.
Diatranz Otsuka Ltd
Live Cell Encapsulation Segment by Type
Alginate
Chitosan
Cellulose
Others
Live Cell Encapsulation Segment by Application
Diabetes
Cancer
Epilepsy
Parkinson
Others
Live Cell Encapsulation Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Live Cell Encapsulation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Live Cell Encapsulation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Live Cell Encapsulation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Live Cell Encapsulation in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Live Cell Encapsulation industry.
Chapter 3: Detailed analysis of Live Cell Encapsulation companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Live Cell Encapsulationrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Alginate
- Chitosan
- Cellulose
- Others
Applications
- Diabetes
- Cancer
- Epilepsy
- Parkinson
- Others
Companies covered
- Viacyte, Inc.
- Living Cell Technologies Ltd.
- Sigilon Therapeutics, Inc
- Sernova Corporation
- PharmaCyte Biotech Inc
- Gloriana Therapeutics
- Kadimastem
- Beta-O2 Technologies, Inc.
- Altucell, Inc.
- Diatranz Otsuka Ltd
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Live Cell Encapsulation Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Alginate
- 1.2.3 Chitosan
- 1.2.4 Cellulose
- 1.2.5 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Live Cell Encapsulation Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Diabetes
- 1.3.3 Cancer
- 1.3.4 Epilepsy
- 1.3.5 Parkinson
- 1.3.6 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Live Cell Encapsulation Growth Trends by Region
- 1.5.1 Global Live Cell Encapsulation Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Live Cell Encapsulation Market Size by Region (2021-2026)
- 1.5.3 Live Cell Encapsulation Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Live Cell Encapsulation Market Dynamics
- 2.1 Live Cell Encapsulation Industry Trends
- 2.2 Live Cell Encapsulation Industry Drivers
- 2.3 Live Cell Encapsulation Industry Opportunities and Challenges
- 2.4 Live Cell Encapsulation Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Live Cell Encapsulation Revenue by Company (2021-2026)
- 3.2 Global Live Cell Encapsulation Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Live Cell Encapsulation Key Company Head office and Area Served
- 3.4 Global Live Cell Encapsulation Company, Product Type & Application
- 3.5 Global Live Cell Encapsulation Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Live Cell Encapsulation Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Live Cell Encapsulation Players Market Share by Revenue in 2025
- 3.6.3 2025 Live Cell Encapsulation Tier 1, Tier 2, and Tier 3
4 Live Cell Encapsulation Market by Type
- 4.1 Global Live Cell Encapsulation Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Live Cell Encapsulation Market Size by Type (2021-2032)
- 4.3 Global Live Cell Encapsulation Market Size Share by Type (2021-2032)
5 Live Cell Encapsulation Market by Application
- 5.1 Global Live Cell Encapsulation Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Live Cell Encapsulation Market Size by Application (2021-2032)
- 5.3 Global Live Cell Encapsulation Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Viacyte, Inc.
- 6.1.1 Viacyte, Inc. Company Information
- 6.1.2 Viacyte, Inc. Business Overview
- 6.1.3 Viacyte, Inc. Live Cell Encapsulation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Viacyte, Inc. Live Cell Encapsulation Product Portfolio
- 6.1.5 Viacyte, Inc. Recent Developments
- 6.2 Living Cell Technologies Ltd.
- 6.2.1 Living Cell Technologies Ltd. Company Information
- 6.2.2 Living Cell Technologies Ltd. Business Overview
- 6.2.3 Living Cell Technologies Ltd. Live Cell Encapsulation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Living Cell Technologies Ltd. Live Cell Encapsulation Product Portfolio
- 6.2.5 Living Cell Technologies Ltd. Recent Developments
- 6.3 Sigilon Therapeutics, Inc
- 6.3.1 Sigilon Therapeutics, Inc Company Information
- 6.3.2 Sigilon Therapeutics, Inc Business Overview
- 6.3.3 Sigilon Therapeutics, Inc Live Cell Encapsulation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Sigilon Therapeutics, Inc Live Cell Encapsulation Product Portfolio
- 6.3.5 Sigilon Therapeutics, Inc Recent Developments
- 6.4 Sernova Corporation
- 6.4.1 Sernova Corporation Company Information
- 6.4.2 Sernova Corporation Business Overview
- 6.4.3 Sernova Corporation Live Cell Encapsulation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Sernova Corporation Live Cell Encapsulation Product Portfolio
- 6.4.5 Sernova Corporation Recent Developments
- 6.5 PharmaCyte Biotech Inc
- 6.5.1 PharmaCyte Biotech Inc Company Information
- 6.5.2 PharmaCyte Biotech Inc Business Overview
- 6.5.3 PharmaCyte Biotech Inc Live Cell Encapsulation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 PharmaCyte Biotech Inc Live Cell Encapsulation Product Portfolio
- 6.5.5 PharmaCyte Biotech Inc Recent Developments
- 6.6 Gloriana Therapeutics
- 6.6.1 Gloriana Therapeutics Company Information
- 6.6.2 Gloriana Therapeutics Business Overview
- 6.6.3 Gloriana Therapeutics Live Cell Encapsulation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Gloriana Therapeutics Live Cell Encapsulation Product Portfolio
- 6.6.5 Gloriana Therapeutics Recent Developments
- 6.7 Kadimastem
- 6.7.1 Kadimastem Company Information
- 6.7.2 Kadimastem Business Overview
- 6.7.3 Kadimastem Live Cell Encapsulation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Kadimastem Live Cell Encapsulation Product Portfolio
- 6.7.5 Kadimastem Recent Developments
- 6.8 Beta-O2 Technologies, Inc.
- 6.8.1 Beta-O2 Technologies, Inc. Company Information
- 6.8.2 Beta-O2 Technologies, Inc. Business Overview
- 6.8.3 Beta-O2 Technologies, Inc. Live Cell Encapsulation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Beta-O2 Technologies, Inc. Live Cell Encapsulation Product Portfolio
- 6.8.5 Beta-O2 Technologies, Inc. Recent Developments
- 6.9 Altucell, Inc.
- 6.9.1 Altucell, Inc. Company Information
- 6.9.2 Altucell, Inc. Business Overview
- 6.9.3 Altucell, Inc. Live Cell Encapsulation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Altucell, Inc. Live Cell Encapsulation Product Portfolio
- 6.9.5 Altucell, Inc. Recent Developments
- 6.10 Diatranz Otsuka Ltd
- 6.10.1 Diatranz Otsuka Ltd Company Information
- 6.10.2 Diatranz Otsuka Ltd Business Overview
- 6.10.3 Diatranz Otsuka Ltd Live Cell Encapsulation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Diatranz Otsuka Ltd Live Cell Encapsulation Product Portfolio
- 6.10.5 Diatranz Otsuka Ltd Recent Developments
7 North America
- 7.1 North America Live Cell Encapsulation Market Size (2021-2032)
- 7.2 North America Live Cell Encapsulation Market Size by Type
- 7.2.1 North America Live Cell Encapsulation Market Size by Type (2021-2026)
- 7.2.2 North America Live Cell Encapsulation Market Size by Type (2027-2032)
- 7.2.3 North America Live Cell Encapsulation Market Share by Type (2021-2032)
- 7.3 North America Live Cell Encapsulation Market Size by Application
- 7.3.1 North America Live Cell Encapsulation Market Size by Application (2021-2026)
- 7.3.2 North America Live Cell Encapsulation Market Size by Application (2027-2032)
- 7.3.3 North America Live Cell Encapsulation Market Share by Application (2021-2032)
- 7.4 North America Live Cell Encapsulation Market Size by Country
- 7.4.1 North America Live Cell Encapsulation Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Live Cell Encapsulation Market Size by Country (2021-2026)
- 7.4.3 North America Live Cell Encapsulation Market Size by Country (2027-2032)
- 7.4.4 North America Live Cell Encapsulation Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Live Cell Encapsulation Market Size (2021-2032)
- 8.2 Europe Live Cell Encapsulation Market Size by Type
- 8.2.1 Europe Live Cell Encapsulation Market Size by Type (2021-2026)
- 8.2.2 Europe Live Cell Encapsulation Market Size by Type (2027-2032)
- 8.2.3 Europe Live Cell Encapsulation Market Share by Type (2021-2032)
- 8.3 Europe Live Cell Encapsulation Market Size by Application
- 8.3.1 Europe Live Cell Encapsulation Market Size by Application (2021-2026)
- 8.3.2 Europe Live Cell Encapsulation Market Size by Application (2027-2032)
- 8.3.3 Europe Live Cell Encapsulation Market Share by Application (2021-2032)
- 8.4 Europe Live Cell Encapsulation Market Size by Country
- 8.4.1 Europe Live Cell Encapsulation Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Live Cell Encapsulation Market Size by Country (2021-2026)
- 8.4.3 Europe Live Cell Encapsulation Market Size by Country (2027-2032)
- 8.4.4 Europe Live Cell Encapsulation Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Live Cell Encapsulation Market Size (2021-2032)
- 9.2 China Live Cell Encapsulation Market Size by Type
- 9.2.1 China Live Cell Encapsulation Market Size by Type (2021-2026)
- 9.2.2 China Live Cell Encapsulation Market Size by Type (2027-2032)
- 9.2.3 China Live Cell Encapsulation Market Share by Type (2021-2032)
- 9.3 China Live Cell Encapsulation Market Size by Application
- 9.3.1 China Live Cell Encapsulation Market Size by Application (2021-2026)
- 9.3.2 China Live Cell Encapsulation Market Size by Application (2027-2032)
- 9.3.3 China Live Cell Encapsulation Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Live Cell Encapsulation Market Size (2021-2032)
- 10.2 Asia Live Cell Encapsulation Market Size by Type
- 10.2.1 Asia Live Cell Encapsulation Market Size by Type (2021-2026)
- 10.2.2 Asia Live Cell Encapsulation Market Size by Type (2027-2032)
- 10.2.3 Asia Live Cell Encapsulation Market Share by Type (2021-2032)
- 10.3 Asia Live Cell Encapsulation Market Size by Application
- 10.3.1 Asia Live Cell Encapsulation Market Size by Application (2021-2026)
- 10.3.2 Asia Live Cell Encapsulation Market Size by Application (2027-2032)
- 10.3.3 Asia Live Cell Encapsulation Market Share by Application (2021-2032)
- 10.4 Asia Live Cell Encapsulation Market Size by Country
- 10.4.1 Asia Live Cell Encapsulation Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Live Cell Encapsulation Market Size by Country (2021-2026)
- 10.4.3 Asia Live Cell Encapsulation Market Size by Country (2027-2032)
- 10.4.4 Asia Live Cell Encapsulation Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Live Cell Encapsulation Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Live Cell Encapsulation Market Size by Type
- 11.2.1 South America, Middle East & Africa Live Cell Encapsulation Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Live Cell Encapsulation Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Live Cell Encapsulation Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Live Cell Encapsulation Market Size by Application
- 11.3.1 South America, Middle East & Africa Live Cell Encapsulation Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Live Cell Encapsulation Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Live Cell Encapsulation Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Live Cell Encapsulation Market Size by Country
- 11.4.1 South America, Middle East & Africa Live Cell Encapsulation Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Live Cell Encapsulation Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Live Cell Encapsulation Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Live Cell Encapsulation Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst